Fusion Pharmaceuticals Probability of Future Stock Price Finishing Over 3.75
| FUSNDelisted Stock | USD 3.75 0.33 8.09% |
Fusion |
Fusion Pharmaceuticals Target Price Odds to finish over 3.75
The tendency of Fusion Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 3.75 | 90 days | 3.75 | more than 94.0 |
Based on a normal probability distribution, the odds of Fusion Pharmaceuticals to move above the current price in 90 days from now is more than 94.0 (This Fusion Pharmaceuticals probability density function shows the probability of Fusion Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Fusion Pharmaceuticals has a beta of 0.29. This usually indicates as returns on the market go up, Fusion Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Fusion Pharmaceuticals will be expected to be much smaller as well. Additionally Fusion Pharmaceuticals has an alpha of 0.0202, implying that it can generate a 0.0202 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Fusion Pharmaceuticals Price Density |
| Price |
Predictive Modules for Fusion Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Fusion Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Fusion Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Fusion Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Fusion Pharmaceuticals is not an exception. The market had few large corrections towards the Fusion Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Fusion Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Fusion Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.02 | |
β | Beta against Dow Jones | 0.29 | |
σ | Overall volatility | 0.40 | |
Ir | Information ratio | -0.01 |
Fusion Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Fusion Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Fusion Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Fusion Pharmaceuticals is not yet fully synchronised with the market data | |
| Fusion Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.07 M. Net Loss for the year was (94.9 M) with loss before overhead, payroll, taxes, and interest of (57.43 M). | |
| Fusion Pharmaceuticals currently holds about 198.42 M in cash with (81.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.57, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 87.0% of the company shares are owned by institutional investors |
Fusion Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Fusion Stock often depends not only on the future outlook of the current and potential Fusion Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Fusion Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 65.6 M | |
| Cash And Short Term Investments | 234.1 M |
Fusion Pharmaceuticals Technical Analysis
Fusion Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Fusion Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Fusion Pharmaceuticals. In general, you should focus on analyzing Fusion Stock price patterns and their correlations with different microeconomic environments and drivers.
Fusion Pharmaceuticals Predictive Forecast Models
Fusion Pharmaceuticals' time-series forecasting models is one of many Fusion Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Fusion Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Fusion Pharmaceuticals
Checking the ongoing alerts about Fusion Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Fusion Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Fusion Pharmaceuticals is not yet fully synchronised with the market data | |
| Fusion Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.07 M. Net Loss for the year was (94.9 M) with loss before overhead, payroll, taxes, and interest of (57.43 M). | |
| Fusion Pharmaceuticals currently holds about 198.42 M in cash with (81.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.57, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 87.0% of the company shares are owned by institutional investors |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Fusion Stock
If you are still planning to invest in Fusion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Fusion Pharmaceuticals' history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |